Phase II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T-Cells and Anti-CTLA4 for Patients With Metastatic Melanoma - Stand Up To Cancer

Blog

Posted October 14, 2019

Phase II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T-Cells and Anti-CTLA4 for Patients With Metastatic Melanoma

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.